Dexcom expects total revenues to be in the band of $4-$4.05 billion for 2024, implying organic growth of 11-13% year over ...

DexCom faces challenges in 2024 due to competition and missteps, but the long-term outlook for continuous glucose monitors ...

In the trailing four quarters, it delivered an earnings beat of nearly 8.3%, on average. More on TNDM’s Latest Integrated Offering G7 is Dexcom’s smallest sensor to date and is hailed as the most ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by ...

The Unified Patent Court in Paris sided with Abbott (NYSE:ABT) following a CGM patent infringement claim from Dexcom ...

DexCom Inc (NASDAQ:DXCM) shares up more than 2% following updated guidelines by the American Diabetes Association (ADA), which now recommend using continuous glucose monitors (CGMs) for some adults ...

Tandem Diabetes Care has received authorization of sale by Health Canada, paving the way for in-warranty t:slim X2 insulin pump users to be full compatibility with both the Dexcom G7 and Dexcom G6 ...

Tandem Diabetes Care announced today that t:slim X2 insulin pump users in Canada can now access full compatibility with ...

Continuous Glucose Monitoring Devices Market was valued at US$ 5.89 Bn in 2024 and is to reach a value of US$ 12.51 Bn by 2031 at a CAGR of 9.9%.

Adults in the US who want to measure their blood glucose levels using a wearable sensor will soon be able to buy one over-the-counter (OTC) for the first time. The FDA has cleared Dexcom’s Stelo ...

OK, I've been a little late coming up with my holiday gift guide, as we've already passed both Black Friday and Cyber Monday.